Pioglitazone in Alzheimer Disease

This study has been completed.

Sponsor:

Collaborator:

Takeda Pharmaceuticals North America, Inc.

Information provided by:

National Institute on Aging (NIA)

ClinicalTrials.gov Identifier:

NCT00982202

First received: September 22, 2009

Last updated: NA

Last verified: September 2009

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)

No publications provided by National Institute on Aging (NIA)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Geldmacher DS, Fritsch T, McClendon MJ, Landreth G. A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease. Arch Neurol. 2011 Jan;68(1):45-50. Epub 2010 Sep 13.

To Top